Mansoor Raza Mirza, Director at Karyopharm Therapeutics Inc. (KPTI), sold 2,056 shares at $20.00 ($41K) on 2020-01-09, disclosed to the SEC on 2020-01-13.
Scheduled sale ($41k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SERA | SELL | 2025-10-06 | $717 | — | Filing → |
| SERA | SELL | 2025-09-05 | $744 | — | Filing → |
| SERA | SELL | 2025-08-05 | $563 | — | Filing → |